May 16, 2023 Ryvu Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
Read More
May 11, 2023 Ryvu Therapeutics to Present Clinical and Preclinical Data on RVU120 at the 2023 European Hematology Association Congress
Read More
March 24, 2023 Ryvu Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Read More
March 15, 2023 Ryvu Therapeutics Named the Stock Exchange Company of the Year
Read More
January 5, 2023 Ryvu Therapeutics to Participate in The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP) Panel and 12th Annual LifeSci Partners Corporate Access Event
Read More
